Think

Search This Blog

Depression and anxiety declined in the first half of 2021 but remained high, the C.D.C. reports.

October 05, 2021

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

BY BENJAMIN MUELLER | NYTimes Health | Disclosure

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says

Results of a large clinical trial found the treatment did not work any better than a placebo. Pam Belluck | NYTimes Health | Disclosure

Following Measles Outbreaks, Officials Grow Wary of Renewed Threat

Cases this year have already topped the total in 2023. Unvaccinated travelers account for most infections. Apoorva Mandavilli | NYTimes Health | Disclosure

Hospitals Must Get Written Patient Consent for Pelvic Exams, H.H.S. Says

In a letter to teaching hospitals, the federal health agency said that institutions could lose Medicare funding if they didn’t comply. Emma Goldberg | NYTimes Health | Disclosure

Patients Hate ‘Forever’ Drugs. Is Wegovy Different?

The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication. Gina Kolata | NYTimes Health | Disclosure

Eclipses Injured Their Eyes, and the World Never Looked the Same

A number of case studies published after recent total solar eclipses highlight the importance of safe viewing. Gina Kolata | NYTimes Health | Disclosure

Depression and anxiety declined in the first half of 2021 but remained high, the C.D.C. reports.

Comments

Post a Comment